Stereotaxis Inc Stock OTC Bulletin Board
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
03-04 | Transcript : Stereotaxis, Inc., Q4 2023 Earnings Call, Mar 04, 2024 | |
03-04 | Earnings Flash (STXS) STEREOTAXIS Reports Q4 Revenue $4.6M, vs. Street Est of $7.7M | MT |
Sales 2024 * | 30.88M 42.19M | Sales 2025 * | 44.25M 60.47M | Capitalization | 189M 258M |
---|---|---|---|---|---|
Net income 2024 * | -19M -25.97M | Net income 2025 * | -16M -21.87M | EV / Sales 2024 * | 6.12 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.27 x |
P/E ratio 2024 * |
-9.79
x | P/E ratio 2025 * |
-12.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.12% |
Latest transcript on Stereotaxis Inc
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 16-09-28 | |
Kimberly Peery
DFI | Director of Finance/CFO | 55 | 02-12-31 |
Laura Garth
LAW | General Counsel | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Messey
BRD | Director/Board Member | 78 | 05-04-30 |
Chief Executive Officer | 57 | 16-09-28 | |
Nathan Fischel
BRD | Director/Board Member | 68 | 17-02-02 |
1st Jan change | Capi. | |
---|---|---|
+8.23% | 219B | |
+6.82% | 183B | |
+11.58% | 133B | |
+25.86% | 108B | |
+1.83% | 63.06B | |
+12.46% | 52.02B | |
-0.62% | 48.2B | |
-0.26% | 40.37B | |
+13.15% | 39.35B |